[go: up one dir, main page]

WO2008008907A3 - Agents antiviraux - Google Patents

Agents antiviraux Download PDF

Info

Publication number
WO2008008907A3
WO2008008907A3 PCT/US2007/073386 US2007073386W WO2008008907A3 WO 2008008907 A3 WO2008008907 A3 WO 2008008907A3 US 2007073386 W US2007073386 W US 2007073386W WO 2008008907 A3 WO2008008907 A3 WO 2008008907A3
Authority
WO
WIPO (PCT)
Prior art keywords
antiviral agents
compositions
compounds
formula
disclosed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2007/073386
Other languages
English (en)
Other versions
WO2008008907A2 (fr
Inventor
Franz Ulrich Schmitz
Christopher Don Roberts
Ronald Conrad Griffith
Janos Botyanszki
Son Minh Pham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genelabs Technologies Inc
Original Assignee
Genelabs Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Technologies Inc filed Critical Genelabs Technologies Inc
Publication of WO2008008907A2 publication Critical patent/WO2008008907A2/fr
Publication of WO2008008907A3 publication Critical patent/WO2008008907A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La présente invention concerne des composés et des compositions de formule (I) et leurs utilisations pour le traitement des infections par un virus de la famille des Flaviviridae.
PCT/US2007/073386 2006-07-14 2007-07-12 Agents antiviraux Ceased WO2008008907A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83104006P 2006-07-14 2006-07-14
US60/831,040 2006-07-14

Publications (2)

Publication Number Publication Date
WO2008008907A2 WO2008008907A2 (fr) 2008-01-17
WO2008008907A3 true WO2008008907A3 (fr) 2008-03-20

Family

ID=38742551

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2007/073391 Ceased WO2008008912A1 (fr) 2006-07-14 2007-07-12 Agents antiviraux
PCT/US2007/073386 Ceased WO2008008907A2 (fr) 2006-07-14 2007-07-12 Agents antiviraux

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2007/073391 Ceased WO2008008912A1 (fr) 2006-07-14 2007-07-12 Agents antiviraux

Country Status (13)

Country Link
EP (1) EP2044083A1 (fr)
JP (1) JP2009543807A (fr)
KR (1) KR20090033881A (fr)
CN (1) CN101490058A (fr)
AR (1) AR062258A1 (fr)
AU (1) AU2007272441A1 (fr)
BR (1) BRPI0714346A2 (fr)
CA (1) CA2657651A1 (fr)
MX (1) MX2009000513A (fr)
PE (1) PE20080427A1 (fr)
RU (1) RU2009105196A (fr)
TW (1) TW200813070A (fr)
WO (2) WO2008008912A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070049593A1 (en) 2004-02-24 2007-03-01 Japan Tobacco Inc. Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
US7659263B2 (en) 2004-11-12 2010-02-09 Japan Tobacco Inc. Thienopyrrole compound and use thereof as HCV polymerase inhibitor
EP2142215B1 (fr) 2007-05-04 2012-03-07 Vertex Pharmceuticals Incorporated Thérapie combinée pour le traitement d'une infection par le vhc
JP2013514982A (ja) 2009-12-18 2013-05-02 イデニク プハルマセウティカルス，インコーポレイテッド ５，５−縮合アリーレン又はヘテロアリーレンｃ型肝炎ウイルス阻害剤
WO2012087833A1 (fr) * 2010-12-22 2012-06-28 Abbott Laboratories Inhibiteurs de l'hépatite c et leurs utilisations
US20120252721A1 (en) * 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
FR3008975A1 (fr) * 2013-07-23 2015-01-30 Servier Lab Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2546006C1 (ru) 2014-03-07 2015-04-10 Римма Ильинична Ашкинази Противовирусное средство
WO2016118043A1 (fr) 2015-01-20 2016-07-28 Виктор Вениаминович ТЕЦ Produit hemostatique
US10167293B2 (en) * 2016-05-26 2019-01-01 Bayer Pharma Aktiengesellschaft [8-(phenylsulfonyl)-3,8-diazabicyclo[3.2.1]oct-3-yl](1H-1,2,3-triazol-4-yl)methanones
JP7475144B2 (ja) 2017-05-24 2024-04-26 ヴェニアミノヴィッチ テッツ ヴィクトル 分画抗菌組成物およびその使用
WO2022221642A1 (fr) 2021-04-16 2022-10-20 Gilead Sciences, Inc. Composés de thiénopyrrole
TW202440078A (zh) 2021-09-10 2024-10-16 美商基利科學股份有限公司 噻吩并吡咯化合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100851A2 (fr) * 2001-06-11 2002-12-19 Shire Biochem Inc. Composes et procedes destines au traitement des infections par flavivirus
WO2004108687A2 (fr) * 2003-06-04 2004-12-16 Genelabs Technologies, Inc. Derives heteroaryles contenant de l'azote

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100851A2 (fr) * 2001-06-11 2002-12-19 Shire Biochem Inc. Composes et procedes destines au traitement des infections par flavivirus
WO2004108687A2 (fr) * 2003-06-04 2004-12-16 Genelabs Technologies, Inc. Derives heteroaryles contenant de l'azote

Also Published As

Publication number Publication date
CN101490058A (zh) 2009-07-22
AU2007272441A1 (en) 2008-01-17
RU2009105196A (ru) 2010-08-27
BRPI0714346A2 (pt) 2013-03-19
JP2009543807A (ja) 2009-12-10
WO2008008912A1 (fr) 2008-01-17
WO2008008907A2 (fr) 2008-01-17
PE20080427A1 (es) 2008-06-11
EP2044083A1 (fr) 2009-04-08
AR062258A1 (es) 2008-10-29
MX2009000513A (es) 2009-03-09
KR20090033881A (ko) 2009-04-06
AU2007272441A2 (en) 2009-03-19
TW200813070A (en) 2008-03-16
CA2657651A1 (fr) 2008-01-17

Similar Documents

Publication Publication Date Title
WO2008008907A3 (fr) Agents antiviraux
WO2008057208A3 (fr) Inhibiteurs de protéase ns3 du vhc
WO2008051514A3 (fr) Inhibiteurs de la protéase ns3 du hcv
WO2008051475A3 (fr) Inhibiteurs de la protéase ns3 du vhc
WO2008051477A3 (fr) Inhibiteurs de la protéase hcv ns3
TW200639169A (en) Bicyclic heteroaryl derivatives for treating viruses
EP1924593B8 (fr) Inhibiteurs de la protease ns3 du vhc
MX2009004556A (es) Inhibidores de la proteasa ns3 del hcv.
WO2006119061A3 (fr) Inhibiteurs de la protease ns3 du vhc
TW200720285A (en) Nucleoside compounds for treating viral infections
WO2007092888A3 (fr) Inhibiteurs ns5b hcv
MY152070A (en) Macrocyclic quinxaline compounds as hcv ns3 protease inhibitors
WO2007140200A3 (fr) Inhibiteurs de la ns5b du vch à base d'indolobenzazépine fusionnée au cyclopropyle
WO2007140254A3 (fr) Inhibiteurs de ns5b de vhc de type indolobenzapénine fusionnée cyclopropyle
MX2011006631A (es) Inhibidores de proteasa ns3 del virus hcv.
WO2013074386A3 (fr) Inhibiteurs de la protéase ns3 du vhc
WO2008070447A3 (fr) Composés anti-viraux
WO2008011521A3 (fr) Inhibiteurs viraux polycycliques
MX2009008872A (es) Compuestos macrociclicos como inhibidores de proteasa ns3 del virus de hepatitis c.
HRP20070435A2 (hr) Triciklički nukleozidni spojevi za liječenje virusnih infekcija
WO2008064218A3 (fr) Composés amido antiviraux
WO2007112028A3 (fr) Phosphonates de 2'-fluoronucléoside en tant qu'agents antiviraux
EA201000201A1 (ru) Азотсодержащие бициклические химические вещества для лечения вирусных инфекций
WO2009026179A3 (fr) Composés de proanthocyanidine anti-infectieux et leurs procédés d'utilisation
WO2008115281A3 (fr) Composés de traitement d'infections virales

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07812863

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07812863

Country of ref document: EP

Kind code of ref document: A2